Search

Your search keyword '"Schetelig, Johannes"' showing total 544 results
Start Over Author "Schetelig, Johannes" Journal blood
544 results on '"Schetelig, Johannes"'

1. Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)

Author

Jost, Edgar, Schmid, Christoph, Baurmann, Herrad, Blau, Igor, Holderried, Tobias, Hertenstein, Bernd, Hänel, Mathias, Bornhäuser, Martin, Neidlinger, Helga, Kobbe, Guido, Winkler, Julia, Schroeder, Thomas, Bug, Gesine, Hopfer, Olaf, Finke, Jürgen, Hasenkamp, Justin, Krüger, William, Müller, Lutz, Kröger, Nikolaus, Eder, Matthias, Luft, Thomas, Hilgendorf, Inken, Ringhoffer, Mark, Stölzel, Friedrich, Scheid, Christoph, Platzbecker, Uwe, Wortmann, Friederike, Heinicke, Thomas, Wagner, Eva, Klein, Stefan, Burchert, Andreas, Tischer, Johanna, Stelljes, Matthias, Schäfer-Eckart, Kerstin, Wolff, Daniel, Junghanss, Christian, Ritter, Markus, Kaufmann, Martin, Bethge, Wolfgang, Mytilineos, Joannis, Einsel, Hermann, Sockel, Katja, Neu, Annika, Goeckenjan, Maren, Ditschkowski, Markus, Kröger, Nicolaus, Ayuk, Francis A., Stoelzel, Friedrich, Middeke, Jan Moritz, Bertz, Hartmut, Beverungen, David, von Bonin, Malte, Egger-Heidrich, Katharina, Heberling, Lisa, Trautmann-Grill, Karolin, Teipel, Raphael, Fraccaroli, Alessia, Fante, Matthias, Scheid, Christof, Holtick, Udo, Blau, Igor Wolfgang, Wulf, Gerald, Schwerdtfeger, Rainer, Kaun, Stephan, Winter, Susann, Theuser, Catrin, Beyersmann, Jan, Bornhaeuser, Martin, Schmeller, Sandra, and Schetelig, Johannes

Published
2024
Full Text
View/download PDF

2. Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial

Author

Fürstenau, Moritz, Giza, Adam, Weiss, Jonathan, Kleinert, Fanni, Robrecht, Sandra, Franzen, Fabian, Stumpf, Janina, Langerbeins, Petra, Al-Sawaf, Othman, Simon, Florian, Fink, Anna-Maria, Schneider, Christof, Tausch, Eugen, Schetelig, Johannes, Dreger, Peter, Böttcher, Sebastian, Fischer, Kirsten, Kreuzer, Karl-Anton, Ritgen, Matthias, Schilhabel, Anke, Brüggemann, Monika, Stilgenbauer, Stephan, Eichhorst, Barbara, Hallek, Michael, and Cramer, Paula

Published
2024
Full Text
View/download PDF

3. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

Author

Taube, Franziska, Georgi, Julia Annabell, Kramer, Michael, Stasik, Sebastian, Middeke, Jan Moritz, Röllig, Christoph, Krug, Utz, Krämer, Alwin, Scholl, Sebastian, Hochhaus, Andreas, Brümmendorf, Tim H., Naumann, Ralph, Petzold, Andreas, Mulet-Lazaro, Roger, Valk, Peter J.M., Steffen, Björn, Einsele, Hermann, Schaich, Markus, Burchert, Andreas, Neubauer, Andreas, Schäfer-Eckart, Kerstin, Schliemann, Christoph, Krause, Stefan W., Hänel, Mathias, Noppeney, Richard, Kaiser, Ulrich, Baldus, Claudia D., Kaufmann, Martin, Herold, Sylvia, Stölzel, Friedrich, Sockel, Katja, von Bonin, Malte, Müller-Tidow, Carsten, Platzbecker, Uwe, Berdel, Wolfgang E., Serve, Hubert, Ehninger, Gerhard, Bornhäuser, Martin, Schetelig, Johannes, and Thiede, Christian

Published
2022
Full Text
View/download PDF

4. Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)

Author

Sockel, Katja, Neu, Annika, Goeckenjan, Maren, Ditschkowski, Markus, Hilgendorf, Inken, Kröger, Nicolaus, Ayuk, Francis A., Stoelzel, Friedrich, Middeke, Jan Moritz, Eder, Matthias, Bethge, Wolfgang, Finke, Jürgen, Bertz, Hartmut, Kobbe, Guido, Kaufmann, Martin, Platzbecker, Uwe, Beverungen, David, Schmid, Christoph, von Bonin, Malte, Egger-Heidrich, Katharina, Heberling, Lisa, Trautmann-Grill, Karolin, Teipel, Raphael, Bug, Gesine, Tischer, Johanna, Fraccaroli, Alessia, Fante, Matthias, Wolff, Daniel, Luft, Thomas, Winkler, Julia, Schäfer-Eckart, Kerstin, Scheid, Christof, Holtick, Udo, Klein, Stefan, Blau, Igor Wolfgang, Burchert, Andreas, Wulf, Gerald, Hasenkamp, Justin, Schwerdtfeger, Rainer, Kaun, Stephan, Junghanss, Christian, Wortmann, Friederike, Winter, Susann, Neidlinger, Helga, Theuser, Catrin, Beyersmann, Jan, Bornhaeuser, Martin, Schmeller, Sandra, Schetelig, Johannes, Jost, Edgar, Schmid, Christoph, Baurmann, Herrad, Blau, Igor, Holderried, Tobias, Hertenstein, Bernd, Hänel, Mathias, Bornhäuser, Martin, Neidlinger, Helga, Kobbe, Guido, Winkler, Julia, Schroeder, Thomas, Bug, Gesine, Hopfer, Olaf, Finke, Jürgen, Hasenkamp, Justin, Krüger, William, Müller, Lutz, Kröger, Nikolaus, Eder, Matthias, Luft, Thomas, Hilgendorf, Inken, Ringhoffer, Mark, Stölzel, Friedrich, Scheid, Christoph, Platzbecker, Uwe, Wortmann, Friederike, Heinicke, Thomas, Wagner, Eva, Klein, Stefan, Burchert, Andreas, Tischer, Johanna, Stelljes, Matthias, Schäfer-Eckart, Kerstin, Wolff, Daniel, Junghanss, Christian, Ritter, Markus, Kaufmann, Martin, Bethge, Wolfgang, Mytilineos, Joannis, and Einsel, Hermann

Abstract

•Successful pregnancies are possible among female alloHCT recipients, although birth rate is >6 times lower than in the general population.•Key factors increasing the chance of pregnancy were younger age at HCT, nonmalignant disease, no TBI or dose <8 Gy and RIC/NMA conditioning

Published
2024
Full Text
View/download PDF

5. Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Author

Röllig, Christoph, Kramer, Michael, Schliemann, Christoph, Mikesch, Jan-Henrik, Steffen, Björn, Krämer, Alwin, Noppeney, Richard, Schäfer-Eckart, Kerstin, Krause, Stefan W., Hänel, Mathias, Herbst, Regina, Kunzmann, Volker, Einsele, Hermann, Jost, Edgar, Brümmendorf, Tim H., Scholl, Sebastian, Hochhaus, Andreas, Neubauer, Andreas, Sohlbach, Kristina, Fransecky, Lars, Kaufmann, Martin, Niemann, Dirk, Schaich, Markus, Frickhofen, Norbert, Kiani, Alexander, Heits, Frank, Krümpelmann, Ulrich, Kaiser, Ulrich, Kullmer, Johannes, Wass, Maxi, Stölzel, Friedrich, von Bonin, Malte, Middeke, Jan Moritz, Thiede, Christian, Schetelig, Johannes, Berdel, Wolfgang E., Ehninger, Gerhard, Baldus, Claudia D., Müller-Tidow, Carsten, Platzbecker, Uwe, Serve, Hubert, and Bornhäuser, Martin

Published
2020
Full Text
View/download PDF

6. External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails

Author

Schetelig, Johannes, Baldauf, Henning, Heidenreich, Falk, Massalski, Carolin, Frank, Sandra, Sauter, Jürgen, Stelljes, Matthias, Ayuk, Francis Ayuketang, Bethge, Wolfgang A., Bug, Gesine, Klein, Stefan, Wendler, Sarah, Lange, Vinzenz, de Wreede, Liesbeth C., Fürst, Daniel, Kobbe, Guido, Ottinger, Hellmut D., Beelen, Dietrich W., Mytilineos, Joannis, Fleischhauer, Katharina, Schmidt, Alexander H., and Bornhäuser, Martin

Published
2020
Full Text
View/download PDF

10. Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial

Author

Röllig, Christoph, primary, Steffen, Björn, additional, Schliemann, Christoph, additional, Mikesch, Jan-Henrik, additional, Alakel, Nael, additional, Herbst, Regina, additional, Haenel, Mathias, additional, Noppeney, Richard, additional, Hanoun, Maher, additional, Kaufmann, Martin, additional, Racil, Zdenek, additional, Schäfer-Eckart, Kerstin, additional, Sauer, Tim, additional, Neubauer, Andreas, additional, Baldus, Claudia D., additional, Mertova, Jolana, additional, Jost, Edgar, additional, Niemann, Dirk, additional, Novak, Jan, additional, Krause, Stefan W., additional, Scholl, Sebastian, additional, Hochhaus, Andreas, additional, Held, Gerhard, additional, Szotkowski, Tomáš, additional, Schmid, Christoph, additional, Rank, Andreas, additional, Fransecky, Lars, additional, Kramer, Michael, additional, Fiebig, Frank, additional, Haake, Annett, additional, Stoelzel, Friedrich, additional, Schetelig, Johannes, additional, Middeke, Jan Moritz, additional, Platzbecker, Uwe, additional, Thiede, Christian, additional, Müller-Tidow, Carsten, additional, Berdel, Wolfgang E., additional, Serve, Hubert, additional, Ehninger, Gerhard, additional, Mayer, Jiří, additional, and Bornhaeuser, Martin, additional

Published
2022
Full Text
View/download PDF

11. Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients &gt;60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

Author

Niederwieser, Dietger, primary, Hasenclever, Dirk, additional, Berdel, Wolfgang E., additional, Biemond, Bart J., additional, Al-Ali, Haifa Kathrin, additional, Chalandon, Yves, additional, Van Gelder, Michel, additional, Junghanss, Christian, additional, Gahrton, Goesta, additional, Haenel, Mathias, additional, Hehlmann, Rüdiger, additional, Heinicke, Thomas, additional, Hochhaus, Andreas, additional, Iacobelli, Simona, additional, Kooy, Rien van Marwijk, additional, Kröger, Nicolaus, additional, Janssen, Jeroen J.W.M., additional, Jentzsch, Madlen, additional, Breywisch, Frank, additional, Mohty, Mohamad, additional, Masouridi-Levrat, Stavroula, additional, Ossenkoppele, Gert, additional, Passweg, Jakob, additional, Pönisch, Wolfram, additional, Schetelig, Johannes, additional, Schliemann, Christoph, additional, Schwind, Sebastian, additional, Stelljes, Matthias, additional, Valk, Peter JM, additional, Lowenberg, Bob, additional, and Cornelissen, Jan J., additional

Published
2022
Full Text
View/download PDF

12. In Patients with Relapsed/Refractory AML Sequential Conditioning and Immediate Allogeneic Stem Cell Transplantation (allo-HCT) Results in Similar Overall and Leukemia-Free Survival Compared to Intensive Remission Induction Chemotherapy Followed By Allo-HCT: Results from the Randomized Phase III ASAP Trial

Author

Stelljes, Matthias, primary, Middeke, Jan Moritz, additional, Bug, Gesine, additional, Wagner, Eva-Maria, additional, Mueller, Lutz Peter, additional, Christoph, Schmid, additional, Krause, Stefan W., additional, Bethge, Wolfgang, additional, Jost, Edgar, additional, Platzbecker, Uwe, additional, Klein, Stefan, additional, Schubert, Jörg, additional, Niederland, Judith, additional, Kaufmann, Martin, additional, Schäfer-Eckart, Kerstin, additional, Schaich, Markus, additional, Baldauf, Henning, additional, Stölzel, Friedrich, additional, Petzold, Cathleen, additional, Röllig, Christoph, additional, Alakel, Nael, additional, Steffen, Björn, additional, Hauptrock, Beate, additional, Reicherts, Christian, additional, Schliemann, Christoph, additional, Serve, Hubert, additional, Schmidt, Alexander H., additional, Bornhäuser, Martin, additional, Mikesch, Jan-Henrik, additional, and Schetelig, Johannes, additional

Published
2022
Full Text
View/download PDF

13. Fast-Track Measurable Residual Disease Detection By Multiparametric Flow Cytometry in Acute Myeloid Leukemia before Allogeneic Hematopoietic Cell Transplantation

Author

Röhnert, Maximilian Alexander, primary, Kramer, Michael, additional, Schadt, Jonas, additional, Ensel, Philipp, additional, Röllig, Christoph, additional, Schetelig, Johannes, additional, Stölzel, Friedrich, additional, Bornhaeuser, Martin, additional, Oelschlägel, Uta, additional, and von Bonin, Malte, additional

Published
2022
Full Text
View/download PDF

14. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Different Donor Types in Primary Refractory Acute Myeloid Leukemia: A Report from the ALWP of the EBMT

Author

Barbullushi, Kordelia, primary, Labopin, Myriam, additional, Kröger, Nicolaus, additional, Finke, Jürgen, additional, Stelljes, Matthias, additional, Ganser, Arnold, additional, Bethge, Wolfgang, additional, Einsele, Hermann, additional, Schetelig, Johannes, additional, Fanin, Renato, additional, Jindra, Pavel, additional, Casper, Jochen, additional, Schroeder, Thomas, additional, Edinger, Matthias, additional, Passweg, Jakob, additional, Forcade, Edouard, additional, Tischer, Johanna, additional, Nagler, Arnon, additional, Ciceri, Fabio, additional, and Mohty, Mohamad, additional

Published
2022
Full Text
View/download PDF

15. Gvhd Prophylaxis Incorporating Methotrexate in Allo-HCT for Chronic Myeloid Malignancies and sAML: A Retrospective Analysis from the Cmwp of the EBMT

Author

Luft, Thomas, primary, Gras, Luuk, additional, Kostner, Linda, additional, Kröger, Nicolaus, additional, Schroeder, Thomas, additional, Platzbecker, Uwe, additional, Schetelig, Johannes, additional, Peffault de Latour, Régis, additional, Stelljes, Matthias, additional, Sengeloev, Henrik, additional, Ganser, Arnold, additional, Blau, Igor Wolfgang, additional, Dreger, Peter, additional, Yakoub-Agha, Ibrahim, additional, Maertens, Johan, additional, Salmenniemi, Urpu, additional, Bethge, Wolfgang, additional, Mielke, Stephan, additional, Kobbe, Guido, additional, Pouli, Anastasia, additional, de Wreede, Liesbeth C., additional, Raj, Kavita, additional, Drozd-Sokolowska, Joanna, additional, McLornan, Donal P., additional, and Robin, Marie, additional

Published
2022
Full Text
View/download PDF

16. Registry Data Indicate a Meaningful Chance for Successful Pregnancies after Allogeneic Stem Cell Transplantation: Results from the German Stem Cell Transplant Registry (DRST)

Author

Sockel, Katja, primary, Frank, Sandra, additional, Neu, Annika, additional, Ditschkowski, Markus, additional, Hilgendorf, Inken, additional, Goeckenjan, Mareen, additional, Stoelzel, Friedrich, additional, Middeke, Jan Moritz, additional, Kröger, Nicolaus, additional, Ayuk, Francis A., additional, Eder, Matthias, additional, Bethge, Wolfgang, additional, Finke, Jürgen, additional, Bertz, Hartmut, additional, Kobbe, Guido, additional, Kaufmann, Martin, additional, Platzbecker, Uwe, additional, Beverungen, David, additional, Schmid, Christoph, additional, von Bonin, Malte, additional, Egger-Heidrich, Katharina, additional, Heberling, Lisa, additional, Trautmann-Grill, Karolin, additional, Teipel, Raphael, additional, Bug, Gesine, additional, Tischer, Johanna, additional, Fraccaroli, Alessia, additional, Holler, Barbara, additional, Wolff, Daniel, additional, Luft, Thomas, additional, Roesler, Wolf, additional, Schäfer-Eckart, Kerstin, additional, Dressler, Sabine, additional, Scheid, Christof, additional, Holtick, Udo, additional, Klein, Stefan, additional, Blau, Igor Wolfgang, additional, Burchert, Andreas, additional, Wulf, Gerald, additional, Hasenkamp, Justin, additional, Schwerdtfeger, Rainer, additional, Kaun, Stephan, additional, Wittke, Christoph, additional, Wortmann, Friederike, additional, Neidlinger, Helga, additional, Bornhaeuser, Martin, additional, Schetelig, Johannes, additional, and of the German Cooperative Transplant Study Group, on Behalf, additional

Published
2022
Full Text
View/download PDF

17. Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome

Author

Georgi, Julia-Annabell, primary, Stasik, Sebastian, additional, Zukunft, Sven, additional, Hartwig, Marita, additional, Röllig, Christoph, additional, Oelschlaegel, Uta, additional, Krug, Utz, additional, Sauer, Tim, additional, Scholl, Sebastian, additional, Hochhaus, Andreas, additional, Brümmendorf, Tim H, additional, Naumann, Ralph, additional, Steffen, Björn, additional, Einsele, Hermann, additional, Schaich, Markus, additional, Burchert, Andreas, additional, Neubauer, Andreas, additional, Schaefer-Eckart, Kerstin, additional, Schliemann, Christoph, additional, Krause, Stefan W., additional, Haenel, Mathias, additional, Noppeney, Richard, additional, Kaiser, Ulrich, additional, Baldus, Claudia D., additional, Kaufmann, Martin, additional, Müller-Tidow, Carsten, additional, Platzbecker, Uwe, additional, Berdel, Wolfgang E., additional, Serve, Hubert, additional, Ehninger, Gerhard, additional, Bornhaeuser, Martin, additional, Schetelig, Johannes, additional, Kroschinsky, Frank P., additional, and Thiede, Christian, additional

Published
2022
Full Text
View/download PDF

18. Venetoclax Plus High-Dose Cytarabine and Mitoxantrone As Feasible and Effective Novel Treatment for Relapsed AML: Results of the Phase-I SAL Relax Trial

Author

Röllig, Christoph, primary, Fransecky, Lars, additional, Hanoun, Maher, additional, Steffen, Björn, additional, Kraus, Sabrina, additional, Schliemann, Christoph, additional, Haake, Annett, additional, Fiebig, Frank, additional, Zukunft, Sven, additional, Alakel, Nael, additional, Middeke, Jan Moritz, additional, Bornhaeuser, Martin, additional, Stoelzel, Friedrich, additional, Schetelig, Johannes, additional, Ruhnke, Leo, additional, Kramer, Michael, additional, Von Bonin, Malte, additional, Röhnert, Maximilian Alexander, additional, Oelschlägel, Uta, additional, Baldus, Claudia D., additional, Serve, Hubert, additional, and Wermke, Martin, additional

Published
2022
Full Text
View/download PDF

19. Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Author

Middeke, Jan M., Fang, Min, Cornelissen, Jan J., Mohr, Brigitte, Appelbaum, Frederick R., Stadler, Michael, Sanz, Jaime, Baurmann, Herrad, Bug, Gesine, Schäfer-Eckart, Kerstin, Hegenbart, Ute, Bochtler, Tilmann, Röllig, Christoph, Stölzel, Friedrich, Walter, Roland B., Ehninger, Gerhard, Bornhäuser, Martin, Löwenberg, Bob, and Schetelig, Johannes

Published
2014
Full Text
View/download PDF

20. Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

Author

Niederwieser, Dietger, Hasenclever, Dirk, Berdel, Wolfgang E., Biemond, Bart J., Al-Ali, Haifa Kathrin, Chalandon, Yves, Van Gelder, Michel, Junghanss, Christian, Gahrton, Goesta, Haenel, Mathias, Hehlmann, Rüdiger, Heinicke, Thomas, Hochhaus, Andreas, Iacobelli, Simona, Kooy, Rien van Marwijk, Kröger, Nicolaus, Janssen, Jeroen J.W.M., Jentzsch, Madlen, Breywisch, Frank, Mohty, Mohamad, Masouridi-Levrat, Stavroula, Ossenkoppele, Gert, Passweg, Jakob, Pönisch, Wolfram, Schetelig, Johannes, Schliemann, Christoph, Schwind, Sebastian, Stelljes, Matthias, Valk, Peter JM, Lowenberg, Bob, and Cornelissen, Jan J.

Published
2022
Full Text
View/download PDF

23. Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial

Author

Dreger, Peter, Döhner, Hartmut, McClanahan, Fabienne, Busch, Raymonde, Ritgen, Matthias, Greinix, Hildegard, Fink, Anna-Maria, Knauf, Wolfgang, Stadler, Michael, Pfreundschuh, Michael, Dührsen, Ulrich, Brittinger, Günter, Hensel, Manfred, Schetelig, Johannes, Winkler, Dirk, Bühler, Andreas, Kneba, Michael, Schmitz, Norbert, Hallek, Michael, and Stilgenbauer, Stephan

Published
2012
Full Text
View/download PDF

24. Prophylactic transfer of BCR-ABL–, PR1-, and WT1-reactive donor T cells after T cell–depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia

Author

Bornhäuser, Martin, Thiede, Christian, Platzbecker, Uwe, Kiani, Alexander, Oelschlaegel, Uta, Babatz, Jana, Lehmann, Doris, Hölig, Kristina, Radke, Jörgen, Tuve, Sebastian, Wermke, Martin, Wehner, Rebekka, Jähnisch, Hanka, Bachmann, Michael P., Rieber, E. Peter, Schetelig, Johannes, Ehninger, Gerhard, and Schmitz, Marc

Published
2011
Full Text
View/download PDF

25. Allogeneic Stem Cell Transplantation in Patients Aged ≥70 Years: Epidemiology, Outcomes, and Risk Factors Based on the German Registry for Stem Cell Transplantation (DRST)

Author

Weller, Jan Frederic, primary, Kaufmann, Louisa, additional, Lengerke, Claudia, additional, Finke, Jürgen, additional, Schetelig, Johannes, additional, Platzbecker, Uwe, additional, Einsele, Hermann, additional, Beelen, Dietrich W., additional, Faul, Christoph, additional, Stelljes, Matthias, additional, Dreger, Peter, additional, Blau, Igor Wolfgang, additional, Wulf, Gerald, additional, Tischer, Johanna, additional, Scheid, Christof, additional, Elmaagacli, Ahmet, additional, Neidlinger, Helga, additional, Frank, Sandra, additional, Bornhäuser, Martin, additional, Bethge, Wolfgang A, additional, Fleischhauer, Katharina, additional, Kröger, Nicolaus, additional, and Christopeit, Maximilian, additional

Published
2021
Full Text
View/download PDF

26. Allogeneic Hematopoietic Cell Transplantation in Patients ≤ 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial-

Author

Bornhaeuser, Martin, primary, Schliemann, Christoph, additional, Schetelig, Johannes, additional, Rollig, Christoph, additional, Kramer, Michael, additional, Glass, Bertram, additional, Platzbecker, Uwe, additional, Burchert, Andreas, additional, Haenel, Mathias, additional, Mueller, Lutz Peter, additional, Klein, Stefan, additional, Bug, Gesine, additional, Beelen, Dietrich W., additional, Roesler, Wolf, additional, Schaefer-Eckart, Kerstin, additional, Schmid, Christoph, additional, Jost, Edgar, additional, Lenz, Georg, additional, Tischer, Johanna, additional, Spiekermann, Karsten, additional, Pfirrmann, Markus, additional, Serve, Hubert, additional, Stoelzel, Friedrich, additional, Alakel, Nael, additional, Ehninger, Gerhard, additional, Berdel, Wolfgang E., additional, and Stelljes, Matthias, additional

Published
2021
Full Text
View/download PDF

27. Prediction of Complete Remission and Survival in Acute Myeloid Leukemia Using Supervised Machine Learning

Author

Eckardt, Jan-Niklas, primary, Rollig, Christoph, additional, Kramer, Michael, additional, Stasik, Sebastian, additional, Georgi, Julia-Annabell, additional, Heisig, Peter, additional, Kroschinsky, Frank P., additional, Schetelig, Johannes, additional, Platzbecker, Uwe, additional, Müller-Tidow, Carsten, additional, Sauer, Tim, additional, Serve, Hubert, additional, Baldus, Claudia D., additional, Schaefer-Eckart, Kerstin, additional, Kaufmann, Martin, additional, Krause, Stefan W., additional, Haenel, Mathias, additional, Schliemann, Christoph, additional, Hanoun, Maher, additional, Thiede, Christian, additional, Bornhaeuser, Martin, additional, Wendt, Karsten, additional, and Middeke, Jan Moritz, additional

Published
2021
Full Text
View/download PDF

28. KIR-HLA Interactions Lack Clinical Utility in Matched Unrelated Donor Transplantation for AML: An Analysis of the CIBMTR and DRST Registries

Author

Fein, Joshua A, primary, Shouval, Roni, additional, Krieger, Elizabeth, additional, Baldauf, Henning, additional, Fleischhauer, Katharina, additional, Kroeger, Nicolaus, additional, Horowitz, Mary M., additional, Maiers, Martin, additional, Malmberg, Karl-Johan, additional, Miller, Jeffrey S., additional, Mohty, Mohamad, additional, Nagler, Arnon, additional, Romee, Rizwan, additional, Schetelig, Johannes, additional, Spellman, Stephen R., additional, Toor, Amir Ahmed, additional, Wang, Tao, additional, Weisdorf, Daniel J., additional, and Koreth, John, additional

Published
2021
Full Text
View/download PDF

29. Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia

Author

Rautenberg, Christina, primary, Stölzel, Friedrich, additional, Röllig, Christoph, additional, Stelljes, Matthias, additional, Gaidzik, Verena I, additional, Lauseker, Michael, additional, Kriege, Oliver, additional, Verbeek, Mareike, additional, Unglaub, Julia M., additional, Thol, Felicitas, additional, Krause, Stefan W., additional, Haenel, Mathias, additional, Neuerburg, Charlotte, additional, Vucinic, Vladan, additional, Jehn, Christian, additional, Severmann, Julia, additional, Wass, Maxi, additional, Fransecky, Lars, additional, Chemnitz, Jens, additional, Holtick, Udo, additional, Schäfer-Eckart, Kerstin, additional, Schröder, Josephine, additional, Kraus, Sabrina, additional, Krüger, William Hermann, additional, Kaiser, Ulrich, additional, Scholl, Sebastian, additional, Henning, Lea, additional, Kobbe, Guido, additional, Haas, Rainer, additional, Alakel, Nael, additional, Röhnert, Maximilian Alexander, additional, Sockel, Katja, additional, Hanoun, Maher, additional, Platzbecker, Uwe, additional, Holderried, Tobias A. W., additional, Morgner, Anke, additional, Heuser, Michael, additional, Sauer, Tim, additional, Goetze, Katharina S., additional, Wagner, Eva Maria, additional, Döhner, Konstanze, additional, Döhner, Hartmut, additional, Schliemann, Christoph, additional, Schetelig, Johannes, additional, Bornhäuser, Martin, additional, Germing, Ulrich, additional, Schroeder, Thomas, additional, and Middeke, Moritz Moritz, additional

Published
2021
Full Text
View/download PDF

30. Venetoclax Plus High-Dose Cytarabine and Mitoxantrone (HAM-Ven) As Salvage Treatment for Relapsed/Refractory AML: Updated Results of the Phase-I/II SAL Relax Trial

Author

Ruhnke, Leo, Schliemann, Christoph, Mikesch, Jan-Henrik, Stelljes, Matthias, Fransecky, Lars, Steffen, Björn, Kaufmann, Martin, Burchert, Andreas, Rank, Andreas, Hanoun, Maher, Höllein, Alexander, Kraus, Sabrina, Hänel, Mathias, Schäfer-Eckart, Kerstin, Haake, Annett, Fiebig, Frank, Zukunft, Sven, Middeke, Jan Moritz, Kunadt, Désirée, Schetelig, Johannes, von Bonin, Malte, Röhnert, Maximilian Alexander, Oelschlägel, Uta, Stölzel, Friedrich, Baldus, Claudia D, Serve, Hubert, Wermke, Martin, Bornhäuser, Martin, and Röllig, Christoph

Published
2023
Full Text
View/download PDF

31. MAIT Cell Frequencies within PBSC Grafts Are Associated with Donor CMV Serostatus and Age: An Initial Analysis from the DKMS and NMDP Graft Composition Study

Author

MacMillan, Hugh R., Minderman, Hans, Spahn, Ashley, Maguire, Orla, Rücker-Braun, Elke, Falk, Bose, Baldauf, Henning, Uhlemann, Heike, Heymann, Nicole, Heiduschke, Lisa, O'Loughlin, Kieran L., Schmidt, Alexander H., Devine, Steven M., Auletta, Jeffery J., Heidenreich, Falk, Feinberg, Jay, Pham, Huy, van den Brink, Marcel R.M., Newell, Evan W., Schetelig, Johannes, Spellman, Stephen R., and Markey, Kate A.

Published
2023
Full Text
View/download PDF

32. Tislelizumab Plus Zanubrutinib in Patients with Richter Transformation: Primary Endpoint Analysis of the Prospective, Multi-Center, Phase-II RT1 Trial of the German CLL Study Group

Author

Al-Sawaf, Othman, Ligtvoet, Rudy, Robrecht, Sandra, Stumpf, Janina, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Böttcher, Sebastian, Mikusko, Martin, Ritgen, Matthias, Schetelig, Johannes, Von Tresckow, Julia, Vehling-Kaiser, Ursula, Wendtner, Clemens-Martin, Fischer, Kirsten, Kreuzer, Karl Anton, Stilgenbauer, Stephan, Staber, Philipp Bernhard, Niemann, Carsten Utoft, Hallek, Michael, and Eichhorst, Barbara F.

Published
2023
Full Text
View/download PDF

33. Long-Term Remissions with MRD-Guided Acalabrutinib, Venetoclax and Obinutuzumab in Relapsed/Refractory CLL: Follow-up Efficacy and Circulating Tumor DNA Analysis of the CLL2-Baag Trial

Author

Furstenau, Moritz, Giza, Adam, Fink, Anna-Maria, Robrecht, Sandra, Weiss, Jonathan, Kleinert, Fanni, Schneider, Christof, Tausch, Eugen, Fischer, Kirsten, Langerbeins, Petra, Al-Sawaf, Othman, Schetelig, Johannes, Dreger, Peter, Böttcher, Sebastian, Kreuzer, Karl-Anton, Ritgen, Matthias, Schilhabel, Anke, Brüggemann, Monika, Stilgenbauer, Stephan, Eichhorst, Barbara F., Hallek, Michael, and Cramer, Paula

Published
2023
Full Text
View/download PDF

34. Risk Stratification of Patients with RUNX1-mutated Acute Myeloid Leukemia

Author

Rausch, Christian, Hornung, Roman, Batcha, Aarif M. N., Rothenberg-Thurley, Maja, Bamopoulos, Stefanos A., Jurinovic, Vindi, Ksienzyk, Bianka, Schneider, Stephanie, Dufour, Annika Maria, Neusser, Michaela, Sauerland, Maria Cristina, Görlich, Dennis, Krug, Utz, Berdel, Wolfgang E., Woermann, Bernhard J., Braess, Jan, Hiddemann, Wolfgang, Meggendorfer, Manja, Kern, Wolfgang, Haferlach, Torsten, Schetelig, Johannes, Middeke, Moritz, Stasik, Sebastian, Egger-Heidrich, Katharina, Röllig, Christoph, Bornhäuser, Martin, Thiede, Christian, Baldus, Claudia D, Müller-Tidow, Carsten, Platzbecker, Uwe, Serve, Hubert, Stock, Wendy, Uy, Geoffrey L, Byrd, John C., Nicolet, Deedra, Eisfeld, Ann-Kathrin, Mansmann, Ulrich, Spiekermann, Karsten, Metzeler, Klaus H, and Herold, Tobias

Published
2023
Full Text
View/download PDF

35. Mimicking Clinical Trials with Synthetic Acute Myeloid Leukemia Patients Using Generative Artificial Intelligence

Author

Eckardt, Jan-Niklas, Hahn, Waldemar, Röllig, Christoph, Stasik, Sebastian, Platzbecker, Uwe, Müller-Tidow, Carsten, Serve, Hubert, Baldus, Claudia D, Schliemann, Christoph, Schäfer-Eckart, Kerstin, Hanoun, Maher, Kaufmann, Martin, Burchert, Andreas, Thiede, Christian, Schetelig, Johannes, Bornhäuser, Martin, Wolfien, Markus, and Middeke, Jan Moritz

Published
2023
Full Text
View/download PDF

36. Impact of KMT2A-PTD Mutational Subgroups on Outcome of AML Patients after Induction Therapy and Allogeneic Hematopoietic Cell Transplantation

Author

Kunadt, Desiree, Zukunft, Sven, Metzeler, Klaus H, Röllig, Christoph, Schliemann, Christoph, Braess, Jan, Müller-Tidow, Carsten, Kraemer, Alwin, Scholl, Sebastian, Hilgendorf, Inken, Jost, Edgar, Steffen, Björn, Bug, Gesine, Einsele, Hermann, Schäfer-Eckart, Kerstin, Krause, Stefan W., Hänel, Mathias, Schroeder, Thomas, Kaufmann, Martin, Middeke, Jan Moritz, Sockel, Katja, Ruhnke, Leo, Platzbecker, Uwe, Serve, Hubert, Stelljes, Matthias, Baldus, Claudia D, Neubauer, Andreas, Schetelig, Johannes, Poitz, David, Thiede, Christian, Bornhäuser, Martin, and Stölzel, Friedrich

Published
2023
Full Text
View/download PDF

37. Unrelated Donors below 35 Years of Age Should be Preferred over HLA-Matched Sibling Donors Older Than 50 Years for Patients with Myeloid Malignancies

Author

Schetelig, Johannes, Baldauf, Henning, Rave, Carina, Bug, Gesine, Mueller, Lutz Peter Hermann, Wagner Drouet, Eva, Ayuk, Francis A., Bethge, Wolfgang Andreas, Stelljes, Matthias, Schröder, Thomas, Kunadt, Desiree, Sockel, Katja, Middeke, Jan Moritz, Fürst, Daniel, Schmidt, Alexander H., Fleischhauer, Katharina, and Bornhäuser, Martin

Published
2023
Full Text
View/download PDF

38. Cryopreservation Changes the Immune Effector Cell Composition of Peripheral Blood Stem Cell Grafts: An Analysis from the DKMS and NMDP Graft Composition Study

Author

Rücker-Braun, Elke, Falk, Bose, Markey, Kate A., Minderman, Hans, Baldauf, Henning, Heymann, Nicole, Uhlemann, Heike, Heiduschke, Lisa, MacMillan, Hugh R., Newell, Evan W., O'Loughlin, Kieran L., Spahn, Ashley, Maguire, Orla, Buk, Deborah, Bornhäuser, Martin, Schmidt, Alexander H., Devine, Steven M., Schetelig, Johannes, Auletta, Jeffery J., van den Brink, Marcel R.M., Spellman, Stephen R., and Heidenreich, Falk

Published
2023
Full Text
View/download PDF

39. Clonal Hematopoiesis Is Common in Unrelated Stem Cell Donors but Has No Impact on Patient Outcome after Hematopoietic Stem Cell Transplantation

Author

Schetelig, Johannes, Damm, Frederik, Günther, Ulf - Peter, Baldauf, Henning, Rave, Carina, Koster, Linda, Schöfl, Gerhard, Klussmeier, Anja, Menghrajani, Kamal, Bolton, Kelly L., Rücker-Braun, Elke, Heidenreich, Falk, Münn, Marie, Fuhrmann, Markus, Visco, Ilaria, Frick, Mareike, Hablesreiter, Raphael, Arends, Christopher Maximilian, de Wreede, Liesbeth C., Nesterenko, Olena, Stelljes, Matthias, Bug, Gesine, Schröder, Thomas, Moiseev, Ivan Sergeevich, Schoemans, Helene, Koenecke, Christian, Teipel, Raphael, von Bonin, Malte, Bullinger, Lars, Bornhäuser, Martin, van den Brink, Marcel R.M., Schmidt, Alexander H., Lange, Vinzenz, Peric, Zinaida, and Penack, Olaf

Published
2023
Full Text
View/download PDF

40. How Much Have Post-Transplant Outcomes Improved Since 2000 for Older Patients with Acute Myeloid Leukemia? a Study from the EBMT Acute Leukemia Working Party

Author

Bazarbachi, Ali, Labopin, Myriam, Moukalled, Nour, Kröger, Nicolaus, Rautenberg, Christina, Schetelig, Johannes, Finke, Jürgen, Wolfgang Blau, Igor, Blaise, Didier, Stelljes, Matthias, Eder, Matthias, Platzbecker, Uwe, Dreger, Peter, Bethge, Wolfgang Andreas, Tischer, Johanna, Burns, David, Sengeloev, Henrik, Brissot, Eolia, Giebel, Sebastian, Nagler, Arnon, Ciceri, Fabio, and Mohty, Mohamad

Published
2023
Full Text
View/download PDF

41. Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1-Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients

Author

Bill, Marius, Eckardt, Jan-Niklas, Rausch, Christian, Metzeler, Klaus H, Spiekermann, Karsten, Stasik, Sebastian, Sauer, Tim, Scholl, Sebastian, Hochhaus, Andreas, Crysandt, Martina, Brümmendorf, Tim H., Krug, Utz, Wörmann, Bernhard, Hiddemann, Wolfgang, Görlich, Dennis, Sauerland, Maria Cristina, Steffen, Björn, Einsele, Hermann, Neubauer, Andreas, Burchert, Andreas, Schaefer-Eckart, Kerstin, Berdel, Wolfgang E., Schliemann, Christoph, Krause, Stefan W., Hanel, Mathias, Hanoun, Maher, Kaufmann, Martin, Fransecky, Lars, Braess, Jan, Ruhnke, Leo, Schetelig, Johannes, Middeke, Jan Moritz, Serve, Hubert, Baldus, Claudia D, Platzbecker, Uwe, Müller-Tidow, Carsten, Bornhäuser, Martin, Herold, Tobias, Thiede, Christian, and Röllig, Christoph

Published
2023
Full Text
View/download PDF

42. Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) for Patients with Myelodysplastic Syndrome (MDS): Comparative Analysis of a Randomized Controlled Trial and Real-World Data

Author

Stelljes, Matthias, Sockel, Katja, Floeth, Matthias, Schetelig, Johannes, Bornhäuser, Martin, Reicherts, Christian, Lenz, Georg, Schröder, Thomas, Trenschel, Rudolf, Markiewicz, Miroslaw, Labussière-Wallet, Hélène, Reményi, Péter, Ciceri, Fabio, and Stölzel, Friedrich

Published
2023
Full Text
View/download PDF

43. Remission and Survival after Single Versus Double Induction with 7+3 for Newly Diagnosed Acute Myeloid Leukemia: Results from the Planned Interim Analysis of Randomized Controlled SAL-Daunodouble Trial

Author

Röllig, Christoph, Steffen, Björn, Alakel, Nael, Herbst, Regina, Noppeney, Richard, Hanoun, Maher, Racil, Zdenek, Schäfer-Eckart, Kerstin, Krämer, Alwin, Neubauer, Andreas, Baldus, Claudia D, Schliemann, Christoph, Kaufmann, Martin, Mertova, Jolana, Jost, Edgar, Niemann, Dirk, Novak, Jan, Krause, Stefan W, Scholl, Sebastian, Held, Gerhard, Parmentier, Stefani B., Szotkowski, Tomáš, Zak, Pavel, Rank, Andreas, Wass, Maxi, Buske, Sebastian, Kramer, Michael, Fiebig, Frank, Haake, Annett, Schetelig, Johannes, Platzbecker, Uwe, Thiede, Christian, Müller-Tidow, Carsten, Berdel, Wolfgang E., Serve, Hubert, Ehninger, Gerhard, Mayer, Jiri, and Bornhäuser, Martin

Published
2020
Full Text
View/download PDF

44. Impact of Genetic Abnormalities and Measurable Residual Disease Levels on Outcome in Patients with MDS/AML Pre-Emptively Treated with Azacitidine: Correlative Results of the Prospective RELAZA2 Trial

Author

Kayser, Sabine, primary, Middeke, Jan Moritz, additional, Kramer, Michael, additional, Sockel, Katja, additional, Stasik, Sebastian, additional, Herbst, Regina, additional, Fransecky, Lars R., additional, Wolf, Dominik, additional, Martin, Schumacher, additional, Krämer, Alwin, additional, Noppeney, Richard, additional, Novotny, Juergen, additional, Bug, Gesine, additional, Götze, Katharina S., additional, Spiekermann, Karsten, additional, Stelljes, Matthias, additional, Mikesch, Jan-Henrik, additional, Subklewe, Marion, additional, Schubert, Antje, additional, Mütherig, Anke, additional, Bochtler, Tilmann, additional, Mende, Marika, additional, Stoelzel, Friedrich, additional, Kubasch, Anne, additional, Von Bonin, Malte, additional, Haenel, Mathias, additional, Duehrsen, Ulrich, additional, Schetelig, Johannes, additional, Rollig, Christoph, additional, Baldus, Claudia D, additional, Ehninger, Gerhard, additional, Müller-Tidow, Carsten, additional, Serve, Hubert, additional, Bornhäuser, Martin, additional, Platzbecker, Uwe, additional, and Thiede, Christian, additional

Published
2020
Full Text
View/download PDF

47. Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Author

Röllig, Christoph, primary, Kramer, Michael, primary, Schliemann, Christoph, primary, Mikesch, Jan-Henrik, primary, Steffen, Björn, primary, Krämer, Alwin, primary, Sauer, Tim, primary, Hänel, Mathias, primary, Herbst, Regina, primary, Schäfer-Eckart, Kerstin, primary, Noppeney, Richard, primary, Jost, Edgar, primary, Brümmendorf, Tim H, primary, Krause, Stefan W, primary, Kunzmann, Volker, primary, Einsele, Hermann, primary, Scholl, Sebastian, primary, Hochhaus, Andreas, primary, Fransecky, Lars R., primary, Kaufmann, Martin, primary, Neubauer, Andreas, primary, Niemann, Dirk, primary, Schaich, Markus, primary, Frickhofen, Norbert, primary, Kiani, Alexander, primary, Heits, Frank, primary, Krümpelmann, Ulrich, primary, Kaiser, Ulrich, primary, Kullmer, Johannes, primary, Wass, Maxi, primary, Klein, Stefan, primary, Von Bonin, Malte, primary, Middeke, Jan Moritz, primary, Thiede, Christian, primary, Stoelzel, Friedrich, primary, Schetelig, Johannes, primary, Ehninger, Gerhard, primary, Baldus, Claudia D, primary, Müller-Tidow, Carsten, primary, Platzbecker, Uwe, primary, Serve, Hubert, primary, and Bornhäuser, Martin, primary

Published
2019
Full Text
View/download PDF

48. Primary Analysis of Anti-CD19 Tafasitamab (MOR208) Treatment in Combination with Idelalisib or Venetoclax in R/R CLL Patients Who Failed Prior BTK Inhibitor Therapy (COSMOS Trial)

Author

Staber, Philipp Bernhard, primary, Jurczak, Wojciech, additional, Brugger, Wolfram, additional, Chanan-Khan, Asher A., additional, Greil, Richard, additional, Hellmann, Andrzej, additional, Dirnberger-Hertweck, Maren, additional, Kelemen, Peter, additional, Middeke, Jan Moritz, additional, Montillo, Marco, additional, Motta, Marina, additional, Munir, Talha, additional, Neumeister, Peter, additional, Niederweiser, Dietger, additional, Parikh, Sameer A., additional, Schetelig, Johannes, additional, Stilgenbauer, Stephan, additional, Vucinic, Vladan, additional, Weirather, Johannes, additional, Woyach, Jennifer, additional, and Wendtner, Clemens-Martin, additional

Published
2019
Full Text
View/download PDF

49. Azacitidine for Pre-Emptive Treatment of Measurable-Residual Disease in MDS/AML Patients at High Risk of Hematological Relapse: Results of the Second Cohort of the RELAZA2 Trial

Author

Platzbecker, Uwe, primary, Middeke, Jan Moritz, primary, Sockel, Katja, primary, Herbst, Regina, primary, Fransecky, Lars R., primary, Wolf, Dominik, primary, Martin, Schumacher, primary, Krämer, Alwin, primary, Noppeney, Richard, primary, Novotny, Juergen, primary, Bug, Gesine, primary, Götze, Katharina, primary, Spiekermann, Karsten, primary, Stelljes, Matthias, primary, Groth, Christoph, primary, Subklewe, Marion, primary, Schubert, Antje, primary, Mütherig, Anke, primary, Bochtler, Tilmann, primary, Mende, Marika, primary, Kubasch, Anne Sophie, primary, Hänel, Mathias, primary, Dührsen, Ulrich, primary, Schetelig, Johannes, primary, Röllig, Christoph, primary, Baldus, Claudia D, primary, Ehninger, Gerhard, primary, Müller-Tidow, Carsten, primary, Serve, Hubert, primary, Kramer, Michael, primary, Bornhäuser, Martin, primary, and Thiede, Christian, primary

Published
2019
Full Text
View/download PDF

50. CEBPAmutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

Author

Taube, Franziska, Georgi, Julia Annabell, Kramer, Michael, Stasik, Sebastian, Middeke, Jan Moritz, Röllig, Christoph, Krug, Utz, Krämer, Alwin, Scholl, Sebastian, Hochhaus, Andreas, Brümmendorf, Tim H., Naumann, Ralph, Petzold, Andreas, Mulet-Lazaro, Roger, Valk, Peter J.M., Steffen, Björn, Einsele, Hermann, Schaich, Markus, Burchert, Andreas, Neubauer, Andreas, Schäfer-Eckart, Kerstin, Schliemann, Christoph, Krause, Stefan W., Hänel, Mathias, Noppeney, Richard, Kaiser, Ulrich, Baldus, Claudia D., Kaufmann, Martin, Herold, Sylvia, Stölzel, Friedrich, Sockel, Katja, von Bonin, Malte, Müller-Tidow, Carsten, Platzbecker, Uwe, Berdel, Wolfgang E., Serve, Hubert, Ehninger, Gerhard, Bornhäuser, Martin, Schetelig, Johannes, and Thiede, Christian

Abstract

Biallelic mutations of the CEBPAgene (CEBPAbi) define a distinct entity associated with favorable prognosis; however, the role of monoallelic mutations (CEBPAsm) is poorly understood. We retrospectively analyzed 4708 adults with acute myeloid leukemia (AML) who had been recruited into the Study Alliance Leukemia trials, to investigate the prognostic impact of CEBPAsm. CEBPAmutations were identified in 240 patients (5.1%): 131 CEBPAbiand 109 CEBPAsm(60 affecting the N-terminal transactivation domains [CEBPAsmTAD] and 49 the C-terminal DNA-binding or basic leucine zipper region [CEBPAsmbZIP]). Interestingly, patients carrying CEBPAbior CEBPAsmbZIPshared several clinical factors: they were significantly younger (median, 46 and 50 years, respectively) and had higher white blood cell (WBC) counts at diagnosis (median, 23.7 × 109/L and 35.7 × 109/L) than patients with CEBPAsmTAD(median age, 63 years, median WBC 13.1 × 109/L; P< .001). Co-mutations were similar in both groups: GATA2mutations (35.1% CEBPAbi; 36.7% CEBPAsmbZIPvs 6.7% CEBPAsmTAD; P< .001) or NPM1mutations (3.1% CEBPAbi; 8.2% CEBPAsmbZIPvs 38.3% CEBPAsmTAD; P< .001). CEBPAbiand CEBPAsmbZIP, but not CEBPAsmTADwere associated with significantly improved overall (OS; median 103 and 63 vs 13 months) and event-free survival (EFS; median, 20.7 and 17.1 months vs 5.7 months), in univariate and multivariable analyses. Additional analyses revealed that the clinical and molecular features as well as the favorable survival were confined to patients with in-frame mutations in bZIP (CEBPAbZIP-inf). When patients were classified according to CEBPAbZIP-infand CEBPAother(including CEBPAsmTADand non-CEBPAbZIP-inf), only patients bearing CEBPAbZIP-infshowed superior complete remission rates and the longest median OS and EFS, arguing for a previously undefined prognostic role of this type of mutation.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results